{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:10:32Z","timestamp":1777590632950,"version":"3.51.4"},"reference-count":20,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2019,1,12]],"date-time":"2019-01-12T00:00:00Z","timestamp":1547251200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/100004460","name":"Rotary International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004460","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,5,24]]},"DOI":"10.1093\/infdis\/jiz026","type":"journal-article","created":{"date-parts":[[2019,1,11]],"date-time":"2019-01-11T07:08:27Z","timestamp":1547190507000},"page":"1887-1892","source":"Crossref","is-referenced-by-count":10,"title":["Poliovirus Type 2 Seroprevalence Following Full- or Fractional-Dose Inactivated Poliovirus Vaccine in the Period After Sabin Type 2 Withdrawal in Sri Lanka"],"prefix":"10.1093","volume":"219","author":[{"given":"Deepa","family":"Gamage","sequence":"first","affiliation":[{"name":"Epidemiology Unit, Ministry of Health, Colombo, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ondrej","family":"Mach","sequence":"additional","affiliation":[{"name":"Polio Eradication Department, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samitha","family":"Ginige","sequence":"additional","affiliation":[{"name":"Epidemiology Unit, Ministry of Health, Colombo, Sri Lanka"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C","family":"Weldon","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Steven","family":"Oberste","sequence":"additional","affiliation":[{"name":"Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Visalakshi","family":"Jeyaseelan","sequence":"additional","affiliation":[{"name":"Polio Eradication Department, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland W","family":"Sutter","sequence":"additional","affiliation":[{"name":"Polio Eradication Department, World Health Organization, Geneva, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,1,14]]},"reference":[{"key":"2019052411105223100_CIT0001","volume-title":"Wild poliovirus list: list of wild poliovirus by country and year"},{"key":"2019052411105223100_CIT0002","doi-asserted-by":"crossref","first-page":"S434","DOI":"10.1093\/infdis\/jiu222","article-title":"The new polio eradication end game: rationale and supporting evidence","volume":"210","author":"Sutter","year":"2014","journal-title":"J Infect Dis"},{"key":"2019052411105223100_CIT0003","volume-title":"Polio eradication and endgame strategic plan 2013\u20132018"},{"key":"2019052411105223100_CIT0004","first-page":"1","article-title":"Meeting of the Strategic Advisory Group of Experts on immunization, November 2013\u2014conclusions and recommendations","volume":"89","year":"2014","journal-title":"Wkly Epidemiol Rec"},{"key":"2019052411105223100_CIT0005","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa1202541","article-title":"Priming after a fractional dose of inactivated poliovirus vaccine","volume":"368","author":"Resik","year":"2013","journal-title":"N Engl J Med"},{"key":"2019052411105223100_CIT0006","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(16)00703-0","article-title":"Humoral and intestinal immunity induced by new schedules of bivalent oral poliovirus vaccine and one or two doses of inactivated poliovirus vaccine in Latin American infants: an open-label randomised controlled trial","volume":"388","author":"Asturias","year":"2016","journal-title":"Lancet"},{"key":"2019052411105223100_CIT0007","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(15)00237-8","article-title":"Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial","volume":"386","author":"Sutter","year":"2015","journal-title":"Lancet"},{"key":"2019052411105223100_CIT0008","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/jix577","article-title":"Immunogenicity of different routine poliovirus vaccination schedules: a randomized, controlled trial in Karachi, Pakistan","volume":"217","author":"Saleem","year":"2018","journal-title":"J Infect Dis"},{"key":"2019052411105223100_CIT0009","volume-title":"SAGE discussion and statement in relation with the IPV supply situation"},{"key":"2019052411105223100_CIT0010","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1016\/j.vaccine.2017.03.008","article-title":"Immunogenicity to poliovirus type 2 following two doses of fractional intradermal inactivated poliovirus vaccine: a novel dose sparing immunization schedule","volume":"35","author":"Anand","year":"2017","journal-title":"Vaccine"},{"key":"2019052411105223100_CIT0011","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.vaccine.2014.11.025","article-title":"Immune responses after fractional doses of inactivated poliovirus vaccine using newly developed intradermal jet injectors: a randomized controlled trial in Cuba","volume":"33","author":"Resik","year":"2015","journal-title":"Vaccine"},{"key":"2019052411105223100_CIT0012","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.vaccine.2011.11.018","article-title":"Intradermal fractional dose inactivated polio vaccine: a review of the literature","volume":"30","author":"Nelson","year":"2012","journal-title":"Vaccine"},{"key":"2019052411105223100_CIT0013","volume-title":"Summary of the April 2017 meeting of the Strategic Advisory Group of Experts on Immunization"},{"key":"2019052411105223100_CIT0014","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1016\/j.jegh.2015.06.004","article-title":"Achieving high seroprevalence against polioviruses in Sri Lanka\u2014results from a serological survey, 2014","volume":"5","author":"Gamage","year":"2015","journal-title":"J Epidemiol Glob Health"},{"key":"2019052411105223100_CIT0015","volume-title":"WHO vaccine-preventable diseases: monitoring system. 2018 global summary"},{"key":"2019052411105223100_CIT0016","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/978-1-4939-3292-4_8","article-title":"Standardized methods for detection of poliovirus antibodies","volume":"1387","author":"Weldon","year":"2016","journal-title":"Methods Mol Biol"},{"key":"2019052411105223100_CIT0017","volume-title":"Bootstrapping (statistics)"},{"key":"2019052411105223100_CIT0018","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ije\/30.5.1029","article-title":"Persistence of vaccine-derived poliovirus following a mass vaccination campaign in Cuba: implications for stopping polio vaccination after global eradication","volume":"30","author":"M\u00e1s Lago","year":"2001","journal-title":"Int J Epidemiol"},{"key":"2019052411105223100_CIT0019","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/ije\/dyg185","article-title":"Poliovirus detection in wastewater and stools following an immunization campaign in Havana, Cuba","volume":"32","author":"M\u00e1s Lago","year":"2003","journal-title":"Int J Epidemiol"},{"key":"2019052411105223100_CIT0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/2224-3151.239418","article-title":"National introduction of fractional-dose inactivated polio vaccine in Sri Lanka following the global \u201cswitch.\u201d","volume":"7","author":"Gamage","year":"2018","journal-title":"WHO South East Asia J Public Health"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jid\/article-pdf\/219\/12\/1887\/28701182\/jiz026.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T11:18:23Z","timestamp":1558696703000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/219\/12\/1887\/5288498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,14]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,1,14]]},"published-print":{"date-parts":[[2019,5,24]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiz026","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,6,15]]},"published":{"date-parts":[[2019,1,14]]}}}